Pages that link to "Q35981069"

The following pages link to The monitoring medicines project: a multinational pharmacovigilance and public health project (Q35981069):

Displaying 12 items.

• Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions (Q33729501) (← links)
• Experiences and Lessons From Implementing Cohort Event Monitoring Programmes for Antimalarials in Four African Countries: Results of a Questionnaire-Based Survey (Q36171629) (← links)
• A review of existing and emerging digital technologies to combat the global trade in fake medicines. (Q38738669) (← links)
• Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies (Q38867438) (← links)
• Identification of Substandard Medicines via Disproportionality Analysis of Individual Case Safety Reports (Q38994263) (← links)
• Standard-based comprehensive detection of adverse drug reaction signals from nursing statements and laboratory results in electronic health records (Q39021112) (← links)
• Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities' Views and Needs (Q39434726) (← links)
• Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance. (Q39538570) (← links)
• Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions. (Q40471702) (← links)
• Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria (Q57488998) (← links)
• Analysis of a pharmacist-led adverse drug event management model for pharmacovigilance in an academic medical center hospital in China (Q59135262) (← links)
• Preventable Cases of Oral Anticoagulant-Induced Bleeding: Data From the Spontaneous Reporting System (Q64079024) (← links)